Recent Headlines
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio. The report provides an extensive study of the contract manufacturing opportunity in this rapidly expanding market. The focus of this report is primarily to... - March 21, 2016 - Roots Analysis
Bioo Scientific Launches ELISA for Screening of Ethoxyquin in Fishmeal, Fish, Shrimp, Feed and Meat
Bioo Scientific has released a new screening method, the MaxSignal® Ethoxyquin ELISA Test Kit to test fishmeal, fish, shrimp, feed and meat for ethoxyquin (EQ) residues. - March 19, 2016 - Bioo Scientific
Bioo Scientific Granted Patent for Small RNA Sequencing Technology
The United States Patent and Trademark Office (USPTO) has issued U.S. patent US9255291 entitled Oligonucleotide ligation, barcoding and methods and compositions for improving data quality and throughput using massively parallel sequencing to Bioo Scientific. - March 17, 2016 - Bioo Scientific
Specialty CROs: The Future of R&D Outsourcing
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016 - Roots Analysis
Spaulding Clinical Research, a Full-Service CRO to Present at the American Society for Clinical Pharmacology and Therapeutics' (ASCPT) 2016 Annual Meeting
Spaulding Clinical Research, LLC, a full-service CRO announced today that they will be in attendance at the American Society for Clinical Pharmacology and Therapeutics’ (ASCPT) 2016 Annual Meeting. The event is scheduled to take place at the Hilton Bayfront in San Diego, California a from... - March 05, 2016 - Spaulding Clinical Research, LLC
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
ImmunoReagents Introduces LigaTrap™ Purification Resins and Kits
ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification. Each kit includes 10 spin columns filled with LigaTrap™ resin and buffers needed to capture species-specific... - February 17, 2016 - ImmunoReagents Inc.
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
Children’s Healthcare of Atlanta Received $1M Research Grant from Enduring Hearts
Children’s Healthcare of Atlanta has received a generous grant of $1,000,000 from the Enduring Hearts Foundation to fund cardiac research to enhance the lives of children needing heart transplantation. Some of the research funded will be that of Michael Davis, Ph.D., Director of the... - January 22, 2016 - Enduring Hearts
Bioo Scientific Completes ISO 9001:2008 Recertification Process
Bioo Scientific has been recertified for another three years under the international ISO 9001:2008 standard (ISO CI#: SARA-2009-CA-0114-A). - January 21, 2016 - Bioo Scientific
Microbiome Therapeutics Market: What’s the Future Potential?
The "Microbiome Therapeutics Market, 2015-2030" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. - January 18, 2016 - Roots Analysis
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
ImaBiotech’s Multimaging™ Technology Chosen by Dermira for Its Skin Disposition Study
ImaBiotech today announced that Dermira, Inc., a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, chose ImaBiotech’s Multimaging technology for a skin disposition study in Yorkshire pigs. Dermira presented the... - December 07, 2015 - Imabiotech
Bioo Scientific Launches Completely Gel-Free or Low Input Small RNA Library Prep Kit
Bioo Scientific recently launched the NEXTflex™ Small RNA-Seq Kit v3, which improves small RNA analysis by making the library prep protocol completely gel-free or allowing for low-input small RNA library preparation. This kit also reduces the biases associated with small RNA sequencing by... - November 25, 2015 - Bioo Scientific
The MaxSignal Colistin ELISA Test Kit Can Help Prevent the Antibiotic Apocalypse by Keeping Last Resort Drugs Out of the Food Supply
Colistin resistance likely emerged after the drug was overused in farm animals. Colistin is intended to be used by physicians as a drug of last resort to treat Gram-negative superbug infections, but has been overused in agriculture. Bioo Scientific’s MaxSignal® Colistin ELISA Test Kit is the only commercially available ELISA optimized for the screening of colistin in poultry and other meat samples and eggs, to prevent the spread of colistin resistance by keeping colistin out of the food supply. - November 25, 2015 - Bioo Scientific
Altogen Biosystems In Vivo Pancreas Kit Has Applications for Diabetes Mellitus and Pancreatic Cancer
As featured by Science magazine, Altogen Biosystems offers a popular line of in vivo transfection reagent kits that include polymer, liposome, nanoparticle and PEG-liposome-based in vivo transfection kits as well as in vivo kits dedicated to targeting tissues, one of which is highlighted here: the... - November 21, 2015 - Altogen Biosystems
Two Research Reports Cite HemogloBind™ for Highly Efficient Sample Preparation
Biotech Support Group reports on two recent research reports which describe the simplicity and efficiency of their proteomic sample preparation technology for hemoglobin depletion. - November 20, 2015 - Biotech Support Group
Update on Glycomics - Achieve Safe, Easy, and Accurate O-Glycan Analysis with BlotGlyco® O-Glycan Sample Preparation Kit
MoBiTec to launch Sumitomo's BlotGlyco® O-Glycan Sample Preparation Kit, a streamlined process for releasing and purifying O-glycans for detection by HPLC, LC-MS, and MALDI-TOF MS. - November 19, 2015 - MoBiTec GmbH
Bioo Scientific Showcases Amplicon Panels and Solutions for Liquid Biopsy Analysis at AMP 2015
At the upcoming Association of Molecular Pathologists (AMP) 2015 Annual Meeting in Austin, TX, Bioo Scientific is launching library preparation solutions ideal for the reduced bias and increased sensitivity, flexibility and speed needed by molecular pathologists for next-generation sequencing applications. These include the NEXTflex Amplicon Panels, the NEXTflex Amplicon Studio service, and the new NEXTflex BRCA1 and BRCA2 Panels. - November 07, 2015 - Bioo Scientific
Clinical Trials in Russia. The Third Quarter 2015.
The Ministry of Health of the Russian Federation approved 203 new clinical trials of all types, including local and bioequivalence studies, during the 3rd Quarter of 2015. This represents a 13% increase over the same period of last year. - October 25, 2015 - Synergy Research Group
Bioo Scientific Releases Low-Input, High Multiplexing Library Prep Solution for SeqCap Target Capture
Bioo Scientific is releasing the new NEXTflex™ Rapid Pre-Capture Combo Kit, a complete low-input library prep solution with the ability to multiplex up to 96 samples, containing the library prep reagents, barcodes, blockers and post-capture amplification reagents required for SeqCap target capture with Roche NimbleGen’s SeqCap EZ solution-based capture system. With this kit, libraries can be constructed from 10 ng of input DNA in only 2 hours. - October 21, 2015 - Bioo Scientific
Altogen Biosystems Develops Powerful In Vivo RNAi Research Tool for Oncology
Lipid-based liposomes of nanometer size are one of the most powerful molecules for delivery of novel therapeutics into target tissues enabling targeted cancer therapeutics. Pharma companies actively investigating new RNAi-based therapeutics where cargo molecules such as a small proteins, DNA,... - October 13, 2015 - Altogen Biosystems
T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis
The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015 - Roots Analysis
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
Bioo Scientific Showcases Solutions Designed to Improve Exome Capture at ASHG 2015
At ASHG 2015, Bioo Scientific is launching a number of new kits for the improvement of in-solution exome and custom target capture. These kits offer optimized library prep, blocking and barcoding, interfacing with Agilent SureSelect XT and XT2 systems and Roche’s Nimblegen SeqCap systems. ASHG is the largest human genetics meeting and expo worldwide, providing a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. - October 09, 2015 - Bioo Scientific
Public Health of Castilla La Mancha Opts for the Legipid Rapid Test for Detecting Legionella in Water
The Public Health Laboratories of Castilla La Mancha (Spain) have introduced the Legipid® Legionella Fast Detection kit to determine Legionella in water. This kit was developed by the company Biotica Bioquimica Analitica (www.biotica.es), which belongs to the Science, Technology and Business Park of the Universitat Jaume I (Espaitec). - October 08, 2015 - Biotica Bioquimica Analitica
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Altogen Biosystems Releases Competitive In Vivo Polymer Kit
Altogen Biosystems has exclusively developed a highly effective In Vivo Polymer Transfection Kit that is capable of delivering siRNA, mRNA, small proteins, and DNA into various rodent tissues for pre-clinical and laboratory research. The efficacy of the Altogen Biosystems new in vivo transfection... - October 02, 2015 - Altogen Biosystems
New Generation of Tissue-Targeted Nanoparticle Based In Vivo Transfection Kit for Animal Research Developed by Altogen Biosystems
Researchers can now effectively deliver molecular targeted medicines into a myriad of tissues using nanotechnology. Altogen Biosystems has developed a new generation of highly efficient Nanoparticle-based In Vivo Transfection Kit that it exclusively manufactures. Nanoparticle technology can be... - October 02, 2015 - Altogen Biosystems
Altogen Biosystems Offers PEG-Liposome In Vivo Transfection Kit
Altogen Biosystems has developed a highly efficient in vivo transfection reagent capable of delivery cargo molecules (siRNA, miRNA, pDNA, and small proteins) into multiple tissues including spleen, kidney, pancreas, liver, and tumors. In vivo transfection is a laboratory research method utilized by... - October 02, 2015 - Altogen Biosystems
Ixogel® is Granted QIDP Status by the US Food and Drug Administration
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG
Bioo Scientific Releases Automated Small RNA Library Prep Protocol for the Sciclone NGS Workstation
Bioo Scientific has automated bias-reducing small RNA library prep on the Sciclone® NGS and NGSx Workstations, automating the NEXTflex™ Small RNA-Seq Library Prep Kit v2 and increasing productivity by reducing the time and labor costs associated with small RNA library prep. - September 26, 2015 - Bioo Scientific
Bioo Scientific Showcases Innovative Solutions for Rapid Food Safety Testing at AOAC 2015
Bioo Scientific will exhibit its latest advances in food and feed safety and quality testing, at booth #502 of the 129th AOAC Annual Meeting, September 27-30 in Los Angeles, CA. New technologies include the most sensitive test available for histamine screening, a sulfite detection method which overcomes issues with problematic “high-creep” samples, optimized immunoaffinity columns for mycotoxin analysis, and a solution for high-throughput detection of amantadine residues in poultry. - September 25, 2015 - Bioo Scientific
MoBiTec GmbH to Attend BIOTECHNICA 2015, Germany - See ZDGSY's Inimitable GS-Key, an Amazingly Small and Fast DNA Extraction Device
BIOTECHNICA - Europe's No.1 Event for Biotechnology, Life Sciences, and Lab Technology! At MoBiTec's booth, cutting-edge technologies will be presented. Highlight: An incredibly small and fast handheld device for DNA extraction! - September 25, 2015 - MoBiTec GmbH
Bioo Scientific Launches Enzymatic Assay for Accurate Homocysteine Analysis in Model Organisms
Bioo Scientific has released the MaxDiscovery™ Homocysteine Enzymatic Assay Kit. This kit uses a new enzymatic technology for spectrophotometric detection of total homocysteine levels in serum from rodents and other mammals. This kit enables the determination of hyperhomocysteinemia, or elevated levels of total homocysteine (tHcy) in the blood, which is an independent risk factor for neural tube defects, vascular diseases and Alzheimer’s disease, and other diseases. - September 23, 2015 - Bioo Scientific
MoBiTec to Offer ProteoGREEN™-gGlu, a Fluorogenic Probe for Specific Detection of Cancer Cells
ProteoGREEN™-gGlu is a cancer-selective fluorogenic imaging probe that is rapidly activated to a highly fluorescent compound. The membrane-permeable dye is suitable for live cells or in vivo imaging of cancer cells. - September 18, 2015 - MoBiTec GmbH
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
Bioo Scientific Receives USDA Approval for Using Its ELISA to Screen Meat for Ractopamine Residues
Bioo Scientific’s MaxSignal® Ractopamine ELISA Test Kit has been approved by the USDA for the verification testing requirements for screening of meat in the Quality System Verification Program (QSVP), Never Fed Beta-Agonists Marketing Program. The kit enables the detection of as little as 0.1 ppb of ractopamine in pork and other meat samples, well below the 1 ppb minimal required performance limit used by many countries. - September 04, 2015 - Bioo Scientific
NASH Drugs Market, 2015-2025
The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis
Protein Expression Systems Market: Current Landscape and Future Opportunities
Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis
VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend
The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC